With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|The TC3 Line, a Zebrafish Model of T-Cell Malignancy||Huntsman Cancer Institute / Nathan Meeker, MD||Young Investigator Grants||2008||Utah|
|Characterization and Targeting of p53 Ubiquitination in Neuroblastoma.||Baylor College of Medicine / Eveline Barbieri, MD, PhD||Young Investigator Grants||2008||Texas|
|Untangling the Matrix in Medulloblastoma||St. Christopher's Hospital for Children / Duncan Stearns, MD||Young Investigator Grants||2008||Ohio|
|Immunotherapeutic Targeting of Stem Cells in Pediatric Brain Tumors||Harbor - UCLA Medical Center / Joseph Lasky||Young Investigator Grants||2008||California|
|Identification and Validation of Differentiation Therapy for Osteosarcoma||Dana-Farber Cancer Institute / Katherine Janeway, MD||Young Investigator Grants||2008||Massachusetts|
|Treatment of high-risk pediatric brain tumors with a CD133-targeted adenovirus in combination with temozolomide||University of Texas M.D. Anderson Cancer Center / Marta Alonso, PhD||Young Investigator Grants||2008||Texas|
|Development of Immunostimulatory DNA as a Novel Therapy in Pediatric Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Alix Seif, MD, MPH||Young Investigator Grants||2008||Pennsylvania|
|Generation of CHD5 Antibodies and Know-out Mouse Model||Children's Hospital of Philadelphia / Garrett Brodeur||Innovation Grants||2008||Pennsylvania|
|Inhibition of Cathepsins to Treat Neuroblastoma||Alfred I duPont Hospital for Children / Robert Mason||Innovation Grants||2008||Delaware|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|